|
Abbreviation
|
Formula
|
Mass
|
Main Class
|
Sub Class
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C58H107NO21
|
1153.733566
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C60H111NO21
|
1181.764866
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C62H115NO21
|
1209.796166
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2
|
C60H110N2O23
|
1226.749944
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C64H119NO21
|
1237.827466
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2
|
C62H114N2O23
|
1254.781245
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C66H121NO21
|
1263.843116
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C66H123NO21
|
1265.858766
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2
|
C64H118N2O23
|
1282.812545
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 44:2;O2
|
C68H125NO21
|
1291.874416
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Fucα1-2Galα1-3Galβ1-4Glcβ-Cer 44:1;O2
|
C68H127NO21
|
1293.890066
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2
|
C66H122N2O23
|
1310.843845
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2
|
C68H124N2O23
|
1336.859495
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2
|
C68H126N2O23
|
1338.875145
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2
|
C70H128N2O23
|
1364.890795
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2
|
C70H130N2O23
|
1366.906445
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2
|
C66H120N2O28
|
1388.802770
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2
|
C68H124N2O28
|
1416.834070
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 34:1;O2
|
C68H123N3O28
|
1429.829318
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2
|
C68H123N3O28
|
1429.829318
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2
|
C70H128N2O28
|
1444.865370
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 36:1;O2
|
C70H127N3O28
|
1457.860618
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2
|
C70H127N3O28
|
1457.860618
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2
|
C72H132N2O28
|
1472.896670
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 38:1;O2
|
C72H131N3O28
|
1485.891919
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2
|
C72H131N3O28
|
1485.891919
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2
|
C74H134N2O28
|
1498.912320
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2
|
C74H136N2O28
|
1500.927970
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 40:1;O2
|
C74H135N3O28
|
1513.923219
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2
|
C74H135N3O28
|
1513.923219
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2
|
C76H138N2O28
|
1526.943620
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2
|
C76H140N2O28
|
1528.959270
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:2;O2
|
C76H137N3O28
|
1539.938869
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:2;O2
|
C76H137N3O28
|
1539.938869
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 42:1;O2
|
C76H139N3O28
|
1541.954519
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 42:1;O2
|
C76H139N3O28
|
1541.954519
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 44:2;O2
|
C78H141N3O28
|
1567.970169
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:2;O2
|
C78H141N3O28
|
1567.970169
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3Galβ1-4Glcβ-Cer 44:1;O2
|
C78H143N3O28
|
1569.985819
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 44:1;O2
|
C78H143N3O28
|
1569.985819
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2
|
C74H133N3O33
|
1591.882144
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2
|
C74H133N3O33
|
1591.882144
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2
|
C76H137N3O33
|
1619.913444
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2
|
C76H137N3O33
|
1619.913444
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 34:1;O2
|
C76H136N4O33
|
1632.908692
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2
|
C78H141N3O33
|
1647.944744
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 38:1;O2
|
C78H141N3O33
|
1647.944744
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcα1-3GalNAcβ1-3Galα1-3(GlcNAcβ1-6)Galβ1-4Glcβ-Cer 36:1;O2
|
C78H140N4O33
|
1660.939992
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
Galα1-3(GalNAcβ1-4Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2
|
C80H145N3O33
|
1675.976044
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|
|
GalNAcβ1-3Galα1-3(Galβ1-4GlcNAcβ1-6)Galβ1-4Glcβ-Cer 40:1;O2
|
C80H145N3O33
|
1675.976044
|
Neutral glycosphingolipids [SP05]
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506]
|